Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion type Assertion NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_head.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion description "[Imatinib mesylate specifically inhibits KIT tyrosine kinase activity, and has been proven to be effective in the treatment of gastrointestinal stromal tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_provenance.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion evidence source_evidence_literature NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_provenance.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion SIO_000772 15469479 NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_provenance.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion wasDerivedFrom befree-2016 NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_provenance.
- NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_assertion wasGeneratedBy ECO_0000203 NP463376.RAo2vyRQ2oCm-PTtXBLq58q6EfPEGCtPt3IhXRkXDo2JA130_provenance.